Home BP vs Office BP Equivalence CKD — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Reversible-cause treatment plus potassium-lowering measures to preserve RAS blockade
Explanation lettering: E = shown as B · B = shown as D · D = shown as E
B is correct. KDIGO emphasises that RAS-inhibitor-associated hyperkalaemia can often be managed rather than automatically withdrawing a drug with kidney and cardiovascular benefit. Confirmation, medication review, constipation and dietary assessment, correction of acidosis, an appropriate diuretic and a modern binder are considered according to context. A makes one moderate result a lifetime contraindication. C adds a common precipitant of both AKI and hyperkalaemia. D intensifies the causal drug. E ignores the stable clinical setting. Acute severity, ECG change and treatment response still determine whether urgent hospital care is needed.
Reference: KDIGO 2024 guideline for CKD evaluation and management: https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf